Semaglutide appears to safeguard the heart even when patients lose little weight. In a massive international trial, heart attack and stroke risk dropped by 20% regardless of BMI. The benefit seems ...
New Scripps Research trial will explore the effects of Lilly’s GLP-1 drug on reducing the symptoms of the debilitating ...
17h
‘I can't shake the anxiety about weight regain if I'm priced out of Mounjaro’: On life after GLP-1s
One writer felt she'd finally reached her bodily happy ever after via GLP-1 jabs. But with soaring prices and scientific unknowns on the horizon...now what?
Just Food on MSN
Product puzzle: food makers weigh up rise of GLP-1 drugs
Today, if a celebrity experiences dramatic weight loss, the first question on anyone’s lips is: are they using Ozempic, Mounjaro – or one of the other branded GLP-1 weight loss management medications?
Baron India Fund has outperformed the MSCI India Index by 660 basis points cumulatively since Fund conversion (effective September 1, 2024).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback